Lista aktualnych publikacji PLRG:
Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study. Walewski J, Kraszewska E, Mioduszewska O, Romejko-Jarosińska J, Hellmann A, Czyz J, Hołowiecki J, Kopera M, Grosicki S, Komarnicki M, Rumianowski L, Kuliczkowski K, Wróbel T, Dwilewicz-Trojaczek J, Robak T, Warzocha K, Załuski J, Wójcik E, Dmoszyńska A, Walter-Croneck A; Polish Lymphoma Research Group.
Med Oncol. 2001;18(2):141-8. doi: 10.1385/mo:18:2:141.
PMID: 11778760 Clinical Trial.
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin’s disease. Retrospective study of the Polish Lymphoma Research Group.
Czyz J, Hellmann A, Dziadziuszko R, Hansz J, Goździk J, Hołowiecki J, Stella-Hołowiecka B, Kachel Ł, Knopińska-Posłuszny W, Nagler A, Meder J, Walewski J, Lampka E, Sułek K, Sawicki W, Lange A, Forgacz K, Suchnicki K, Pacuszko T, Skotnicki A, Mensah P, Jurczak W, Kuliczkowski K, Wróbel T, Mazur G, Dmoszyńska A, Wach M, Robak T, Warzocha K.
Bone Marrow Transplant. 2002 Jul;30(1):29-34. doi: 10.1038/sj.bmt.1703590.
PMID: 12105774
[Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin’s lymphoma. The experience of Polish lymphoma research group].
Hołowiecki J, Giebel S, Walewski J, Krawczyk-Kuliś M, Hellmann A, Skotnicki A, Dmoszyńska A, Romejko J, Czyz J, Jurczak W, Kachel Ł, Wojnar J, Stella-Hołowiecka B, Saduś-Wojciechowska M, Sułek K, Jedrzejczak W, Robak T, Mariańska B, Szczylik C, Warzocha K.
Pol Arch Med Wewn. 2003 Aug;110(2):863-8. PMID: 14682225 Clinical Trial. Polish.
Radioimmunotherapy in follicular lymphomas, a retrospective analysis of the Polish Lymphoma Research Group’s (PLRG) experience.
Jurczak W, Hubalewska-Dydejczyk A, Giza A, Sowa-Staszczak A, Wróbel T, Mazur G, Boguradzki P, Knopińska-Posłuszny W, Huszno B, Skotnicki AB.
Nucl Med Rev Cent East Eur. 2007;10(2):91-7. PMID: 18228213
Two autologous transplants in the treatment of patients with Hodgkin’s lymphoma: analysis of prognostic factors and comparison with a single procedure.
Czyz J, Dziadziuszko R, Knopinska-Posłuszny W, Hellmann A, Kachel L, Hołowiecki J, Czyz A, Komarnicki M, Osowiecki M, Walewski J, Jurczak W, Skotnicki A; Polish Lymphoma Research Group.
Leuk Lymphoma. 2007 Mar;48(3):535-41. doi: 10.1080/10428190601158621.
PMID: 17454595
Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.
Kalinka-Warzocha E, Wajs J, Lech-Maranda E, Ceglarek B, Holowiecki J, Federowicz I, Walewski J, Czyz J, Robak T, Warzocha K; Polish Lymphoma Research Group.
Cancer. 2008 Jul 15;113(2):367-75. doi: 10.1002/cncr.23558.
PMID: 18470902 Clinical Trial.
Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers.
Jurczak W, Kroll-Balcerzak R, Giebel S, Machaczka M, Giza A, Ogórka T, Fornagiel S, Rybka J, Wróbel T, Kumiega B, Skotnicki AB, Komarnicki M. Med Oncol. 2015 Apr;32(4):90. doi: 10.1007/s12032-015-0520-3. Epub 2015 Feb 26.
PMID: 25716885
Distribution of lymphomas in Poland according to World Health Organization classification: analysis of 11718 cases from National Histopathological Lymphoma Register project – the Polish Lymphoma Research Group study.
Szumera-Ciećkiewicz A, Gałązka K, Szpor J, Rymkiewicz G, Jesionek- Kupnicka D, Gruchała A, Ziarkiewicz-Wróblewska B, Poniatowska-Broniek G, Demczuk S, Prochorec-Sobieszek M.
Int J Clin Exp Pathol. 2014 May 15;7(6):3280-6. eCollection 2014. PMID: 25031749
Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group.
Jurczak W, Ochrem B, Giza A, Zimowska-Curyło D, Górecki T, Boguradzki P, Knopińska-Posłuszny W, Stella-Hołowiecka B, Walewski J, Joks M, Wróbel T, Zaucha JM.
Pol Arch Med Wewn. 2015;125(10):741-8. doi: 10.20452/pamw.3113. Epub 2015 Sep 3.
PMID: 26334344
Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group.
Giebel S, Sadus-Wojciechowska M, Halaburda K, Drozd-Sokolowska J, Wierzbowska A, Najda J, Mendrek W, Sobczyk-Kruszelnicka M, Nowicki M, Holowiecki J, Czerw T.
Ann Hematol. 2016 Jan;95(2):263-9. doi: 10.1007/s00277-015-2557-y.
Epub 2015 Nov 27.
PMID: 26611854
Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma.
Sokolowska-Wojdylo M, Florek A, Zaucha JM, Chmielowska E, Giza A, Knopinska-Posluszny W, Kulikowski W, Prejzner W, Romejko-Jarosinska J, Paszkiewicz-Kozik E, Osowiecki M, Walewski J, Rogowski W, Grzanka A, Placek W, Lugowska-Umer H, Kowalczyk A, Nowicki R, Jurczak W.
Am J Ther. 2016 May-Jun;23(3):e749-56. doi: 10.1097/MJT.0000000000000056.
PMID: 24732904
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post- Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S.
J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564.
Epub 2016 Dec 19.
PMID: 27992268 Clinical Trial.
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study.
Zaucha JM, Malkowski B, Chauvie S, Subocz E, Tajer J, Kulikowski W, Fijolek-Warszewska A, Biggi A, Fallanca F, Kobylecka M, Dziuk M, Woszczyk D, Rybka J, Kroll-Balcerzak R, Bergesio F, Romanowicz A, Chamier-Cieminska A, Kurczab P, Giza A, Lesniewski-Kmak K, Zaucha R, Swietlik D, Wróbel T, Knopinska-Posluszny W, Walewski J, Gallamini A. Ann Oncol. 2017 Dec 1;28(12):3051-3057. doi: 10.1093/annonc/mdx524. PMID: 28950332
Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group.
Wróbel T, Biecek P, Rybka J, Szulgo A, Sorbotten N, Giza A, Tyczyńska A, Nowara E, Badora-Rybicka A, Adamowicz K, Kulikowski W, Kroll-Balcerzak R, Balcerzak A, Spychałowicz W, Kalinka-Warzocha E, Kumiega B, Drozd- Sokołowska J, Subocz E, Sałek A, Machaczka M, Hołojda J, Pogrzeba J, Dobrzyńska O, Chmielowska E, Jurczak W, Knopińska-Posłuszny W, Leśniewski-Kmak K, Maciej Zaucha J.
Leuk Lymphoma. 2019 Feb;60(2):341-348. doi: 10.1080/10428194.2018.1482539. Epub 2018 Jul 6.
PMID: 29979097
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkinlymphoma-Polish Lymphoma Research Group real-life analysis. Długosz-Danecka M, Hus I, Puła B, Jurczyszyn A, Chojnacki T, Blajer- Olszewska B, Drozd-Sokołowska J, Raźny M, Romejko-Jarosińska J, Taszner M, Jurczak W.
Pharmacol Rep. 2019 Jun;71(3):473-477. doi: 10.1016/j.pharep.2019.02.001. Epub 2019 Feb 6.
PMID: 31003160
Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.
Jurczak W, Gruszka AM, Sowa Staszczak A, Dlugosz-Danecka M, Szostek M, Zimowska-Curylo D, Giza A, Krawczyk K, Jakobczyk M, Hubalewska-
Dydejczyk A, Szymczyk M, Wróbel T, Knopińska-Posłuszny W, Kisiel E, Skotnicki A, Zinzani PL.
Leuk Lymphoma. 2019 Nov;60(11):2689-2696. doi: 10.1080/10428194.2019.1602261. Epub 2019 Apr 9.
PMID: 30961415 Clinical Trial.
Hepatitis B virus screening in patients with non-Hodgkin lymphoma in clinical practice in Poland – a report of the Polish Lymphoma Research Group.
Kalinka E, Drozd-Sokołowska J, Waszczuk-Gajda A, Barankiewicz J, Zalewska E, Symonowicz I, Lech-Marańda E.
Arch Med Sci. 2019 Jul 18;16(1):157-161. doi: 10.5114/aoms.2019.86761.
eCollection 2020.
PMID: 32051719
Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.
Drozd-Sokołowska J, Zaucha JM, Żółtak T, Jamroziak K, Grzybowska- Izydorczyk O, Witkowska M, Waszczuk-Gajda A, Kaźmierczak M, Szczepaniak A, Subocz E, Knopińska-Posłuszny W, Hołojda J, Kopińska A, Hus I, Rybka J, Wołowiec D, Kwiatkowski J, Hałaburda K, Smolewski P, Giebel S, Wiktor-Jędrzejczak W.
Hematol Oncol. 2019 Oct;37(4):383-391. doi: 10.1002/hon.2624. Epub 2019 Jun 14.
PMID: 31026087
Safety and Efficacy of Bendamustine Monotherapy in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: Polish Lymphoma Research Group Real-Life Analysis.
Wołowiec D, Szymczyk A, Potoczek S, Krochmalczyk D, Zawirska D, Piotrowska M, Malenda A, Soroka-Wojtaszko M, Kopacz A, Wąsik- Szczepanek E, Graboś-Michalak J, Raźny M, Wichary R, Bramowicz- Jarosz B, Seweryn M, Długosz-Danecka M, Hus I.
Chemotherapy. 2019;64(3):155-162. doi: 10.1159/000503220. Epub 2019
Nov 12.
PMID: 31715597
Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP – the PLRG report.
Drozd-Sokolowska J, Zaucha JM, Biecek P, Giza A, Kobylinska K, Joks M, Wrobel T, Kumiega B, Knopinska-Posluszny W, Spychalowicz W, Romejko- Jarosinska J, Fischer J, Wiktor-Jedrzejczak W, Dlugosz-Danecka M, Giebel S, Jurczak W.Sci Rep. 2020 Feb 26;10(1):3517. doi: 10.1038/s41598-020-
60565-7.PMID: 32103128 Free PMC article. Clinical Trial.
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Walewski J, Paszkiewicz-Kozik E, Michalski W, Rymkiewicz G, Szpila T, Butrym A, Giza A, Zaucha JM, Kalinka-Warzocha E, Wieczorkiewicz A, Zimowska-Curyło D, Knopińska-Posłuszny W, Tyczyńska A, Romejko- Jarosińska J, Dąbrowska-Iwanicka A, Gruszecka B, Jamrozek-Jedlińska M, Borawska A, Hołda W, Porowska A, Romanowicz A, Hellmann A, Stella- Hołowiecka B, Deptała A, Jurczak W.
Br J Haematol. 2020 Mar;188(6):898-906. doi: 10.1111/bjh.16264. Epub 2019 Dec 2.
PMID: 31792945 Free PMC article. Clinical Trial.
Primary cutaneous indolent B-cell lymphomas – a retrospective multicenter analysis and a review of literature.
Olszewska-Szopa M, Sobas M, Laribi K, Bao Perez L, Drozd-Sokołowska J, Subocz E, Joks M, Zduniak K, Gajewska M, de Nalecz AK, Romejko- Jarosińska J, Kumiega B, Waszczuk-Gajda A, Wróbel T, Czyz A.Acta Oncol. 2021 Oct;60(10):1361-1368. doi: 10.1080/0284186X.2021.1956689. Epub
2021 Aug 4.PMID: 34346830 Review.
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Paszkiewicz-Kozik E, Michalski W, Taszner M, Mordak-Domagała M, Romejko-Jarosińska J, Knopińska-Posłuszny W, Najda J, Borawska A, Chełstowska M, Świerkowska M, Dąbrowska-Iwanicka A, Malenda A, Druzd-Sitek A, Konecki R, Kumiega B, Osowiecki M, Ostrowska B, Szpila T, Szymański M, Targoński Ł, Domańska-Czyż K, Popławska L, Giebel S, Lange A, Pluta A, Zaucha JM, Rymkiewicz G, Walewski J.Br J Haematol.
2022 Jul;198(1):73-81. doi: 10.1111/bjh.18166. Epub 2022 Apr
1.PMID: 35362096
Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia-A Multicenter Report by the Polish Lymphoma Research Group.
Drozd-Sokołowska J, Waszczuk-Gajda A, Witkowska M, Sienkiewicz E, Kopińska A, Kołkowska-Leśniak A, Barankiewicz J, Długosz-Danecka M, Smolewski P, Helbig G, Lech-Marańda E, Jurczak W, Biecek P, Giebel S, Wiktor-Jędrzejczak W, Basak G.
J Clin Med. 2022 Jul 30;11(15):4447. doi: 10.3390/jcm11154447.
PMID: 35956064 Free PMC article.
Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group.
Paszkiewicz-Kozik E, Debowska M, Jakacka N, Kotarska M, Szymanski M, Wisniewski K, Konska A, Jarzembowska M, Drozd-Sokolowska J, Romejko- Jarosinska J, Szumera-Cieckiewicz A, Rymkiewicz G, Ziarkiewicz- Wroblewska B, Lech-Maranda E, Walewski J, Hus I.
Chemotherapy. 2022;67(4):201-210. doi: 10.1159/000523921. Epub 2022
Mar 4.
PMID: 35249035
A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG).
Kalicińska E, Giza A, Zaucha JM, Giebel S, Zimowska-Curyło D, Andrasiak I, Spychałowicz W, Wojnar J, Balcerzak A, Romejko-Jarosińska J, Paszkiewicz-Kozik E, Knopińska-Posłuszny W, Rybka J, Jabłonowska P, Wróbel T.
Cancer Med. 2023 Feb;12(3):3036-3045. doi: 10.1002/cam4.5223. Epub 2022 Sep 26.
PMID: 36161781
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group.
Paszkiewicz-Kozik E, Hus I, Palka M, Dębowska M, Końska A, Kotarska M, Tyczyńska A, Joks M, Twardosz M, Giza A, Wąsik-Szczepanek E, Kalicińska E, Wiśniewska A, Morawska M, Lewicka B, Szymański M, Targoński Ł, Romejko-Jarosińska J, Drozd-Sokołowska J, Subocz E, Swoboda R, Długosz-Danecka M, Lech-Maranda E, Walewski J.
Adv Clin Exp Med. 2023 Jan;32(1):131-136. doi: 10.17219/acem/157290. PMID: 36603138
Autoimmune cytopenias in patients with malignant lymphoma: A multicenter report by the Polish Lymphoma Research Group.
Witkowska M, Drozd-Sokołowska J, Waszczuk-Gajda A, Giza A, Lewicka B, Zdziarska J, Mikulski D, Smolewski P.
Adv Clin Exp Med. 2023 Nov 28. doi: 10.17219/acem/174502. Online ahead of print.
PMID: 38014929
Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre- Existing Arterial Hypertension-Real World Data of the Polish Lymphoma Research Group.
Szmit S, Długosz-Danecka M, Drozd-Sokołowska J, Joks M, Szeremet A, Jurczyszyn A, Jurczak W.
Heart Lung Circ. 2024 Apr 13:S1443-9506(24)00157-4. doi: 10.1016/j.hlc.2024.03.003. Online ahead of print.
PMID: 38616466
